Visit Lucid news for the latest in psychedelics
Research shows that psychedelics can be effective at treating a variety of mental health conditions and physical illnesses.
To learn best practices developed by harm reduction experts for the novice and intrepid psychonaut alike, start here.
Psychedelic therapy shows promise as a treatment for anxiety, including social anxiety and end-of-life anxiety
Research suggests that some psychedelic compounds may be useful in treating depression in conjunction with therapy
Studies suggest that psychedelic therapy could be an effective treatment for alcoholism and opioid dependency
Studies suggest ketamine-assisted therapy is a promising treatment for depression due to its fast-acting ability to relieve depressive symptoms.
MDMA-assisted therapy has the potential to treat PTSD due to its effects on the amygdala, the part of the brain that processes fear that’s overactive in PTSD patients.
Studies suggest that psilocybin-assisted therapy can help with smoking cessation for over a year after treatment.
Learn more about psilocybin mushrooms and smoking cessation.
Psilocybin-induced mystical experiences have been associated with reduced anxiety in terminally ill patients.
Learn more about psilocybin as an end-of-life anxiety treatment.
Research suggests that ketamine-assisted therapy may be a safe and effective treatment for anxiety disorders.
Search Psychedelic U to learn and discover.
UPDATED: August 2nd, 2023
Ketamine research also suggests it has pain relieving qualities . A 2004 study analyzed…
UPDATED: August 2nd, 2023
Ketamine is being used to treat an array of mental health conditions and substance…
UPDATED: July 21st, 2023
MDMA has the potential to be a treatment for the symptoms of PTSD for…
UPDATED: July 21st, 2023
Research suggests ketamine can help with symptoms of generalized anxiety disorder and social anxiety.…
UPDATED: July 21st, 2023
One of the most promising uses of ketamine in the mental health field is…
UPDATED: July 21st, 2023
A landmark study on the use of LSD to treat alcohol use disorder occurred…
Recent research surveying 1,435 microdosers suggests that microdosing’s duration of effect might be more like that of drinking a coffee, with benefits that come and go by day’s end.
A new report from the RAND Corporation shows that nearly one-quarter of U.S. adults now support the legal use of psilocybin with public support driven by approval for therapeutic not personal access or recreational use.
After publishing a new study investigating synthetic analogs for iboga molecules, scientist and co-founder of Gilgamesh Pharmaceuticals, Dalibor Sames, decided to take the compound he has described as an intelligent molecular machine.